Filing Details
- Accession Number:
- 0000899243-18-020583
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-25 17:09:15
- Reporting Period:
- 2018-07-19
- Accepted Time:
- 2018-07-25 17:09:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1737953 | Replimune Group Inc. | REPL | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1361712 | Otello Stampacchia | 185 Dartmouth Street Boston MA 02116 | Yes | No | Yes | No | |
1528382 | Omega Fund Iv, L.p. | 185 Dartmouth Street Boston MA 02116 | No | No | Yes | No | |
1528383 | Omega Fund Iv Gp, L.p. | 185 Dartmouth Street Boston MA 02116 | No | No | Yes | No | |
1623720 | J. Richard Lim | 185 Dartmouth Street Boston MA 02116 | No | No | Yes | No | |
1624456 | Omega Fund Iv G.p. Manager, Ltd. | 185 Dartmouth Street Boston MA 02116 | No | No | Yes | No | |
1652863 | Anne-Mari Paster | 185 Dartmouth Street Boston MA 02116 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-07-24 | 266,667 | $15.00 | 266,667 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-07-24 | 994,688 | $0.00 | 1,261,355 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2018-07-24 | 2,579,881 | $0.00 | 3,841,236 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2018-07-24 | 1,013,547 | $0.00 | 4,854,783 | No | 4 | C | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | C | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Series Seed Preferred Stock | Series Seed Warrants (right to buy) | Disposition | 2018-07-24 | 25,000 | $0.00 | 25,000 | $0.00 |
Common Stock | Common Stock Warrants (right to buy) | Acquisiton | 2018-07-24 | 248,672 | $0.00 | 248,672 | $0.00 |
Common Stock | Series Seed Preferred Stock | Disposition | 2018-07-24 | 100,000 | $0.00 | 994,688 | $0.00 |
Common Stock | Series A Convertible Preferred Stock | Disposition | 2018-07-24 | 259,366 | $0.00 | 2,579,881 | $0.00 |
Common Stock | Series B Convertible Preferred Stock | Disposition | 2018-07-24 | 101,896 | $0.00 | 1,013,547 | $0.00 |
Common Stock | Common Stock Option | Acquisiton | 2018-07-19 | 13,500 | $0.00 | 13,500 | $15.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct | ||
248,672 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct | ||
13,500 | No | 4 | A | Direct |
Footnotes
- The reported securities are beneficially owned by Omega Fund IV, L.P. ("Omega IV"). The reported securities may be deemed to be beneficially owned by each of Omega Fund IV GP, L.P. ("Omega IV GP"), as the general partner of Omega IV, and Omega Fund IV GP Manager, Ltd. ("Omega IV GP Manager"), as the general partner of Omega IV GP. Otello Stampacchia, Richard Lim and Anne-Mari Paster are all the shareholders and directors of Omega IV GP Manager and have shared voting and investment power over the shares held by Omega IV and, as a result, may each be deemed to beneficially own the reported securities. Otello Stampacchia is also a director of the issuer. Each of the Reporting Persons disclaims beneficial ownership of the reported securities, except to the extent of his, her or its pecuniary interest therein.
- The Series Seed Preferred Stock ("Series Seed") converted automatically into shares of the issuer's common stock on a 1-for-9.94688 basis upon the completion of the issuer's public offering of common stock pursuant the issuer's registration statement under the Securities Act of 1933, as amended, filed with the Commission on June 22, 2018, as subsequently amended (the "IPO"). The Series Seed had no expiration date.
- The Series A Convertible Preferred Stock ("Series A") converted automatically into shares of the issuer's common stock on a 1-for-9.94688 basis upon the completion of IPO. The Series A had no expiration date.
- The Series B Convertible Preferred Stock ("Series B") converted automatically into shares of the issuer's common stock on a 1-for-9.94688 basis upon the completion of IPO. The Series B had no expiration date.
- The Series Seed Warrants (the "Seed Warrants") converted automatically in warrants to purchase shares of the issuer's common stock (the "Common Stock Warrants") on a 1-for-9.94688 basis upon the completion of IPO. The exercise price of the Common Stock Warrants is $1.01 per share of the issuer's common stock. The Seed Warrants had no expiration date and the Common Stock Warrants have no expiration date.
- The Common Stock Options (the "Options") were granted to Otello Stampacchia in his capacity as a director of the issuer on July 19, 2018 (the "Grant Date") contingent upon the closing of the IPO, with 25% of the Options vesting on the first anniversary of the Grant Date and an additional 3.125% of the Options vesting each month thereafter for 24 months. The Options expire on the tenth anniversary of the Grant Date.